Copyright
©The Author(s) 2023.
World J Gastrointest Oncol. Sep 15, 2023; 15(9): 1567-1594
Published online Sep 15, 2023. doi: 10.4251/wjgo.v15.i9.1567
Published online Sep 15, 2023. doi: 10.4251/wjgo.v15.i9.1567
Figure 7 Establishment of a prognostic nomogram for clinical practice in the TCGA-LIHC dataset.
A: Univariate-cox regression results of the cellular-senescence-relevant gene signature and conventional clinicopathological parameters with hepatocellular carcinoma prognosis; B: Multivariate Cox regression for selecting independent prognostic parameters; C: Generation of a nomogram based on stage and the cellular senescence-relevant RiskScore; D–F: Decision curve analysis at 1-, 1-, and 5-year survival.
- Citation: Wang HH, Chen WL, Cui YY, Gong HH, Li H. Cellular senescence throws new insights into patient classification and pharmacological interventions for clinical management of hepatocellular carcinoma. World J Gastrointest Oncol 2023; 15(9): 1567-1594
- URL: https://www.wjgnet.com/1948-5204/full/v15/i9/1567.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v15.i9.1567